Mirae Asset Global Investments Co., Ltd. Precigen, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $28 Billion
- Q2 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Precigen, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 11,403 shares of PGEN stock, worth $20,867. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,403
Previous 9,800
16.36%
Holding current value
$20,867
Previous $14,000
14.29%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding PGEN
# of Institutions
153Shares Held
164MCall Options Held
1.11MPut Options Held
36.8K-
Third Security, LLC83.5MShares$153 Million73.5% of portfolio
-
Patient Capital Management, LLC Baltimore, MD17.4MShares$31.8 Million1.48% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA11.3MShares$20.6 Million0.03% of portfolio
-
Black Rock Inc. New York, NY10.2MShares$18.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.8MShares$16.1 Million0.0% of portfolio
About PRECIGEN, INC.
- Ticker PGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 208,150,000
- Market Cap $381M
- Description
- Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...